Learn more

SCANCELL LTD

Overview
  • Total Patents
    90
  • GoodIP Patent Rank
    44,619
  • Filing trend
    ⇧ 300.0%
About

SCANCELL LTD has a total of 90 patent applications. It increased the IP activity by 300.0%. Its first patent ever was published in 1997. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are CANCER ADVANCES INC, YOUNG DAVID S F and ARACLON BIOTECH SL.

Patent filings per year

Chart showing SCANCELL LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Durrant Linda Gillian 61
#2 Brentville Victoria Anne 27
#3 Metheringham Rachel Louise 22
#4 Metheringham Rachael Louise 14
#5 Parsons Tina 12
#6 Pudney Victoria Anne 11
#7 Ellis John Robert Maxwell 6
#8 Xue Wei 4
#9 Victoria Anne Brentville 3
#10 Robins Adrian 3

Latest patents

Publication Filing date Title
GB202101435D0 Nucleic acids and polypeptides encoded thereby
GB202018395D0 Immunotherapy
GB202013385D0 Nucleic acids and polypeptides encoded thereby
GB202005779D0 Anti-tumour immune responses
GB201912882D0 Ssea-4 binding members
GB201912657D0 Binding members
GB201910900D0 Modified fc-regions to enhance functional affinity of antibodies and antigen binding fragments thereof
GB201910899D0 Binding members
GB201815041D0 Epitopes
GB201512703D0 Anti-tumour immune responses to modified self-epitopes
GB201214007D0 Anti-tumour immune responses to modified self-epitopes
GB0706070D0 Nucleic acids
GB0410627D0 Specific binding members
ZA200208739B Humanised antibodies to the epidermal growth factor receptor.
GB0111628D0 Binding member
GB0102145D0 Substances
GB0020794D0 Humanised antibodies